Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Alpha Tau Medical (DRTSW)

Alpha Tau Medical Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRTSW
DateTimeSourceHeadlineSymbolCompany
18/12/202413:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
18/12/202413:30GlobeNewswire Inc.Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update DayNASDAQ:DRTSWAlpha Tau Medical Ltd
17/12/202414:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
17/12/202414:00GlobeNewswire Inc.Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as AdvisorNASDAQ:DRTSWAlpha Tau Medical Ltd
17/12/202413:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
11/12/202413:30GlobeNewswire Inc.Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
06/12/202413:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
06/12/202413:30GlobeNewswire Inc.Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors SymposiumNASDAQ:DRTSWAlpha Tau Medical Ltd
19/11/202421:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
19/11/202421:00GlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
13/11/202413:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
13/11/202413:30GlobeNewswire Inc.Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
21/10/202412:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
21/10/202412:30GlobeNewswire Inc.Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma MultiformeNASDAQ:DRTSWAlpha Tau Medical Ltd
10/10/202412:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
10/10/202412:30GlobeNewswire Inc.Alpha Tau Treats First Patient with Recurrent Lung CancerNASDAQ:DRTSWAlpha Tau Medical Ltd
20/09/202412:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
20/09/202412:30GlobeNewswire Inc.Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCCNASDAQ:DRTSWAlpha Tau Medical Ltd
22/08/202412:30GlobeNewswire Inc.Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor ConNASDAQ:DRTSWAlpha Tau Medical Ltd
14/08/202420:02GlobeNewswire Inc.Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
25/06/202412:30GlobeNewswire Inc.Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial CancersNASDAQ:DRTSWAlpha Tau Medical Ltd
21/05/202412:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
21/05/202412:45GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Global Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
20/05/202420:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
20/05/202420:01GlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
13/05/202420:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
13/05/202412:30GlobeNewswire Inc.Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerNASDAQ:DRTSWAlpha Tau Medical Ltd
06/05/202412:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
06/05/202412:30GlobeNewswire Inc.Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowNASDAQ:DRTSWAlpha Tau Medical Ltd
01/05/202412:30GlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSWAlpha Tau Medical Ltd
 Showing the most relevant articles for your search:NASDAQ:DRTSW

Your Recent History

Delayed Upgrade Clock